In the early 1930s, Rife identified two cancer-associated organisms:
In 1934, Dr. Milbank Johnson organized a 90-day clinical trial in La Jolla to treat 16 terminal cancer patients using Rife's Ray Tube machine.
The treatment protocol used Rife’s frequency generator with a plasma ray tube and was overseen by medical doctors.
Rife documented specific frequencies in his lab notes for BX (cancer) and BY (sarcoma), around 21 kHz and 20 kHz, respectively.
They often combined his treatments with supportive therapies to enhance results:
Did You Know?
Hydrazine sulfate has since been studied independently and shown in some cases to slow cancer growth. However, it is not FDA-approved for cancer treatment.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.